AQR Arbitrage’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,782
Closed -$3.95M 828
2023
Q2
$3.95M Hold
12,782
0.17% 155
2023
Q1
$3.89M Sell
12,782
-143
-1% -$43.1K 0.12% 224
2022
Q4
$3.84M Hold
12,925
0.1% 285
2022
Q3
$3.76M Sell
12,925
-11,942
-48% -$3.48M 0.08% 333
2022
Q2
$7.22M Buy
24,867
+10,000
+67% +$2.91M 0.16% 169
2022
Q1
$4.34M Hold
14,867
0.11% 215
2021
Q4
$4.3M Buy
+14,867
New +$4.33M 0.11% 204

Other funds holding XAGE

AQR Arbitrage's XAGE Position: Q3 2023 in Review

AQR Arbitrage sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2023, closing a stake of 12,782 shares — an estimated $3.95M sold.

AQR Arbitrage first reported a position in XAGE in Q4 2021 and held it in 7 quarters. The position peaked at $7.22M in Q2 2022. 14 funds tracked by Wall St. Rank hold XAGE as of Q3 2023.

  • AQR Arbitrage reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • AQR Arbitrage sold 12,782 Longevity Health Holdings, Inc. Common Stock shares in Q3 2023, an estimated $3.95M.
  • AQR Arbitrage first reported a position in Longevity Health Holdings, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • AQR Arbitrage's Longevity Health Holdings, Inc. Common Stock position peaked at $7.22M in Q2 2022.
  • 14 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2023.

Based on AQR Arbitrage's 13F filing for Q3 2023, filed 14 Nov 2023.